...
首页> 外文期刊>World Journal of Gastroenterology >Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.
【24h】

Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.

机译:慢性丙型肝炎的聚乙二醇干扰素治疗可能与视网膜分支静脉血栓形成和视力丧失有关。

获取原文
获取原文并翻译 | 示例
           

摘要

Ophthalmological complications with interferon therapy are usually mild and reversible, not requiring the withdrawal of the treatment. We report a case of a patient who had visual loss probably associated with interferon therapy. Chronic hepatitis C virus infection (genotype 1a) was diagnosed in a 33-year old asymptomatic man. His past medical history was unremarkable and previous routine ophthalmologic check-up was normal. Pegylated interferon alpha and ribavirin were started. Three weeks later he reported painless reduction of vision. Ophthalmologic examination showed extensive intraretinal hemorrhages and cotton-wool spots, associated with inferior branch retinal vein thrombosis. Antiviral therapy was immediately discontinued, but one year later he persists with severely decreased visual acuity. This case illustrates the possibility of unpredictable and severe complications during pegylated interferon therapy.
机译:干扰素治疗的眼科并发症通常是轻度且可逆的,不需要停止治疗。我们报告了一例患者的视力下降,可能与干扰素治疗有关。一名33岁无症状男子被诊断出慢性丙型肝炎病毒感染(基因型1a)。他过去的病史不明显,以前的常规眼科检查正常。开始聚乙二醇化干扰素α和利巴韦林。三个星期后,他报告无痛的视力下降。眼科检查显示广泛的视网膜内出血和棉绒斑点,与视网膜下支静脉血栓形成有关。立即终止抗病毒治疗,但一年后,他继续视力严重下降。该病例说明了聚乙二醇化干扰素治疗期间发生不可预测的严重并发症的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号